Skip to main content
. 2022 Aug 19;129(4):588–597. doi: 10.1016/j.bja.2022.06.019

Table 3.

Variables included in the multivariable adjusted, multilevel Cox proportional hazards model before time-varying stratification of complication. Random effects components were country nested within study, and the value represents the standard deviation of the intercept for the log hazard ratio. ∗P-value <0.05. P-value for global Schoenfeld test=0.03. ASA, American Society of Anesthesiologists; CI, confidence interval; COPD, chronic obstructive pulmonary disease.

Feature Adjusted hazard ratio (95% CI) z
Complication within 30 days 1.94 (1.53–2.46) 5.55∗
Age (1 yr increment) 1.04 (1.03–1.05) 7.38∗
Sex: female vs male 0.73 (0.58–0.93) –2.98∗
ASA physical status: 2 vs 1 1.63 (0.9–2.95) 1.64
ASA physical status: 3 vs 1 3.15 (1.71–5.8) 3.72∗
ASA physical status: 4 vs 1 6.11 (2.85–13.13) 4.72∗
Smoking status: current vs not current 1.45 (1.04–2.02) 6.2∗
Operative severity: low vs high 1.07 (0.73–1.56) 0.41
Operative severity: moderate vs high 1.15 (0.89–1.48) 1.07
Surgery for cancer 2.89 (2.24–3.72) 8.17∗
Coronary artery disease 0.36 (0.17–0.74) –2.58∗
Cardiac failure 0.65 (0.3–1.38) –0.84
Cancer 1.59 (0.78–3.23) 1.72
Diabetes mellitus 0.42 (0.2–0.86) –2.14∗
Stroke 1.25 (0.84–1.86) 1.08
COPD 0.48 (0.23–1) –1.67
Chronic kidney disease 0.59 (0.29–1.23) –1.23
Number of diseases: 1 vs 0 2.53 (1.21–5.28) 2.10∗
Number of diseases: 2 vs 0 5.64 (1.4–22.68) 2.24∗
Number of diseases: ≥3 vs 0
15.33 (1.72–136.85)
2.15∗
Random effects components
Study/country
Country
Standard deviation
0.65
1.20
Variance
0.42
1.45